Displaying 51–75 of 249 results for Paul Thomas, Senior Editor

Sort By Relevance Sort By Date
1 2 3 4 5 ...10

PharmaView: Sell No Harm

(Article)

Makers of drugs for lethal injection face pressure to spurn U.S. prisons.

The Need for New Models in Identifying New Molecules

(Article)

Probabilistic rather than deterministic modeling is essential, says Quintiles’ Davis Walp.

The Good Fight: The Plight of Pharma's Middle Managers

(Article)

Middle managers in pharma today have a tough, thankless job—but someone’s got to do it, and many do it well.

Shoring Up Pharma’s Middle Management

(Article)

Organizations with built-in risk management frameworks allow middle managers to thrive, says Scott Chizzo, Maxiom Group’s president and chief consultant, in this exclusive interview.

Tales from the Middle

(Article)

Pharma's middle managers carry on despite a "damned if we do, damned if we don't" environment.

Exploring Fluorescence as an Online PAT Solution

(Article)

Mike Ponstingl, owner of Custom Sensors & Technology, shares insight into new methods of monitoring fermentation and other bioprocesses.

Managing Change Management in Pharma: A Talk with Bill Wilder

(Article)

People generally don’t resist change, says the Life Cycle Institute's Bill Wilder. “They resist being changed when they don't know why.”

PharmaView: Shattered Trust in Manufacturing and FDA, a Renewed Faith in the ...

(Article)

A Milwaukee newspaper reminds an industry of its flaws.

Creative and Cautious: How Pharma’s Managers-Once-Removed Can Claim Relevance

(Article)

Industry consultant Jane Chin examines what makes the jobs of pharma’s middle managers so tough, and how they can succeed against the odds.

Sustainability in the Genes: A Talk With DSM Chief Xander Wessels

(Article)

In this interview, Wessels talks with PharmaManufacturing.com Senior Editor Paul Thomas about why sustainability matters, and how sustainable practices can become part of a drug manufacturer’s genetic makeup.

Serialization & Traceability: Where Pharma Stands

(Article)

A new survey sheds light upon choices and challenges.

June 2011

June 2011 Issue of Pharmaceutical Manufacturing

Pharma Asset Management: Sizing Up the Global Secondary Market

(Article)

As pharma and biopharma companies deal with turbulent times, they look to a more sophisticated (and even real-time) secondary market to help manage equipment and assets. An industry expert surveys the scene, and provides smart shopping and selling advice, software

PharmaView: Can RFID Make Waves Again?

(Article)

Reports of the demise of radio frequency identification as a breakthrough supply chain technology have been greatly exaggerated.

Does RFID Have an Impact Upon Biologic Drugs?

(Article)

Recent research suggests not, and prompts FDA to clarify its position on the issue.

New Technologies: Continuous Effluent Decontamination for Pharma Facilities

(Article)

Steris Finn-Aqua has developed a new technology for the automatic decontamination of pharma/biopharma effluent.

Bioprocess Filtration: Debating Post-sterilization Integrity Testing

(Article)

At PDA 2011, at issue was whether current EMA guidelines are rational or risky; also, a look at new filtration products on the market.

Is Wireless Ready for Bioprocess Monitoring . . . and Control?

(Article)

Smart phones and similar devices are pushing the wireless envelope, but wireless process control still faces traditional hurdles.

On Developing an OpEx Culture at Elan

(Article)

Elan's head of manufacturing, Kevin Brady, talks about what works, and why.

PharmaView: What's the Prescription for Painkiller Nation?

(Article)

With FDA and the Obama administration on alert, it is drug manufacturers' turn to address a crisis.

Pre-Proof of Concept Flow Chemistry Modeling at Pfizer

(Article)

A summary of Pfizer's Martin Guinn talk from the DynoChem 2011 user group.

Levels of Uncertainty: Incorporating Common Cause Variability into the Design...

(Article)

A summary of Lilly's Shankar Vaidyaraman's talk from the DynoChem 2011 user group.

Lilly's Viswanath: Moving Towards a Global Understanding of Product Design

(Article)

A summary of Lilly's Shekhar Viswanath talk from the DynoChem 2011 user group.

Keeping FDA Happy: Proactive and Reactive Best Practices

(Article)

Know when you’re on shaky ground, and then respond promptly and thoroughly to FDA’s requests, says J&J Janssen’s Patti Gupta.

What’s Your True Green?

(Article)

If it can’t be measured, it can’t be green; leading manufacturers are turning to advanced metrics to show just how sustainable their products, processes, and plants really are.

Sort By Relevance Sort By Date
1 2 3 4 5 ...10